Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1681/ASN.0000000832 | DOI Listing |
Publication Analysis
Top Keywords
authors' reply
4
reply ravulizumab
4
ravulizumab iga
4
iga nephropathy
4
nephropathy promising
4
promising step
4
step disease
4
disease modification?
4
authors'
1
ravulizumab
1
Similar Publications
Reply by Authors.
J Urol
September 2025
Division of Radiation Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada.
Authors' reply to comment on "effectiveness and tolerability of methylthioninium chloride (methylene blue) for the treatment of methemoglobinemia: twenty-four years of experience at a single poison center".
Clin Toxicol (Phila)
September 2025
Division of Medical Toxicology, Ronald O. Perelman Department of Emergency Medicine, NYU Grossman School of Medicine, New York, NY, USA.
Reply to: "Rethinking risk indices in pediatric MASLD".
JHEP Rep
October 2025
Department of Family Medicine, Yonsei University College of Medicine, Yongin Severance Hospital, Yongin-si, Republic of Korea.
Authors' Reply to Merz et al. on eCPR in New Zealand.
Emerg Med Australas
October 2025
Department of Internal Medicine I: Cardiology and Conservative Intensive Care Medicine, Helios Dr. Horst Schmidt Kliniken Wiesbaden, Wiesbaden, Hesse, Germany.